Active Ingredient: DARIFENACIN HYDROBROMIDE
Proprietary Name: DARIFENACIN HYDROBROMIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 7.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207681
Product Number: 001
Approval Date: Dec 8, 2017
Applicant Holder Full Name: ALEMBIC PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
